2021 American Transplant Congress

TOPIC: Clinical Science

Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective
K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida
Recipient and Kidney Allograft Outcomes from Hypertensive Live-Donor in the United States
S. Riad¹, S. Jackson², D. Vock³, A. Matas⁴
Recipient Selector for Donation After Cardiac Death Allografts
G. Handing¹, S. Ganni², S. Barrett¹, N. Galvan², C. O’Mahony², J. Goss², R. Cotton², A. Rana²
Recurrence and Outcome of Anti-GBM Glomerulonephritis After Kidney Transplantation: A Belgian Multicenter Study
S. Coche
Reducing Rejection in Pediatric Kidney Transplantation: The Improving Renal Outcomes Collaborative (iroc)
C. Varnell¹, A. Warmin¹, G. Barletta², C. Belsha³, L. Harshman⁴, D. Kershaw⁵, C. Pruette⁶, S. Ranabothu⁷, M. Seifert⁸, P. Singer⁹, M. Yanik¹⁰, K. Rich¹, A. Modi¹, D. Hooper¹
Reduction in Hospitalizations and Deaths in Covid-19 Positive Abdominal Organ Transplant Recipients Following Implementation of A Protocol for Early Treatment with Bamlanivimab
A. Ahearn, T. Maw, J. Emamaullee, J. Kim, E. Blodget, J. Kahn, C. Goldbeck, L. Sher, Y. Genyk
Regional Impact of Covid-19 on Kidney Transplant in the Southeast
C. Jay¹, B. Sharda¹, R. Helmick², R. Forbes³, V. Casingal⁴, R. Stratta¹
Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis
C. L. Hanlon¹, B. Saberi², L. Yuan¹
Relationship Between %dd-cfDNA, MMDx Molecular Diagnoses, and Donor-specific Antibody in the Trifecta Study
P. F. Halloran¹, L. G. Hildago², J. Reeve¹, Z. Demko³, A. Prewett³, P. Billings³, J. Truong⁴, P. Vander Horn⁴, &. Trifecta Study Group⁵
Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients
D. D. de Lucena, I. A. de Brito, M. P. Cristelli, J. O. Medina-Pestana, H. Tedesco-Silva, É. B. Rangel